16 August 2021
Life sciences businesses risk losing access to R&D tax credits during fundraising rounds.
22 July 2021
We explain how the RDEC scheme works, what rate of relief is available, what expenditure qualifies for the relief and the evidence required for your claim. We also cover how large corporations and SMEs can make best use of the scheme and how we can help.
25 March 2021
From 1 April 2021, small and medium-sized enterprises (SMEs) considering making a research and development (R&D) tax relief claim will need to carefully consider the impact of a new cap on payable tax credits.
03 March 2021
The Chancellors plan to launch a review of the current Research and Development (R&D) tax incentives builds on previous consultation, revealing the Government’s focus towards keeping the UK at the forefront of innovation.
02 October 2020
The latest HMRC statistics on Research & Development tax relief reveal that in 20 years, over 300,000 claims have been made, delivering £33.3bn of tax relief to UK businesses since its introduction in 2000.
23 June 2020
The extent of planned capital expenditure (capex) cuts by large listed companies in the UK was last week predicted to reach somewhere in the region of £23bn. CFOs seem to favour cash preservation over investment. What can Government do to lure business leaders away from their spending funk? Boosting the level of R&D tax relief available and relaxing the qualifying criteria would be a good starting point.
21 April 2020
Following enquiries by RSM, HMRC has confirmed that R&D repayment claims will not be offset against tax liabilities under COVID-19 deferral schemes. However, payments of tax that are delayed under time-to-pay agreements with HMRC remain subject to offset.
20 April 2020
RSM has contacted HMRC’s policy team to ask how R&D repayment claims will be treated in light of the government’s support schemes to help businesses cope with the coronavirus outbreak. Find out the answer here.